Jacobs Levy Equity Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-95,726	Closed	-$3.64M	–	1090
2022 Q4	$3.64M	Sell	95,726 -22,247	-19%	-$845K	0.02%	451
2022 Q3	$2.97M	Buy	+117,973	New	+$2.97M	0.02%	485